findmyKOL
Clinical trialNCT03977467CompletedPhase 2Interventional

Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor

SponsorSCRI Development Innovations, LLCEnrollment46Non-Small Cell Lung CancerSolid Tumor
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Florida Cancer Specialists - South

    Fort Myers, Florida, United States

  • Florida Cancer Specialists - North

    St. Petersburg, Florida, United States

  • Florida Cancer Specialists - Panhandle

    Tallahassee, Florida, United States

  • Florida Cancer Specialists - East

    West Palm Beach, Florida, United States

  • Midamerica Division, Inc., C/o Research Medical Center (hca Midwest)

    Kansas City, Missouri, United States

  • Tennessee Oncology - Chattanooga

    Chattanooga, Tennessee, United States

  • Tennessee Oncology, Pllc

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Aug 2019
Primary completion
9 Aug 2024
Completion
9 Aug 2024
Last update posted
27 Aug 2025
Registered enrollment
46
Registry id
NCT03977467
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.